CC-BY-NC-ND 4.0 · Joints 2017; 05(04): 207-211
DOI: 10.1055/s-0037-1607427
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Revision Total Knee Arthroplasty with Metaphyseal Sleeves without Stem: Short-Term Results

Giacomo Stefani1, Valerio Mattiuzzo1, Greta Prestini1
  • 1Dipartimento Di Ortopedia 2, Istituto Clinico “Città di Brescia,” Brescia, Italy
Further Information

Publication History

Publication Date:
30 October 2017 (eFirst)


Purpose The aim of this study was to evaluate the efficacy of revision total knee arthroplasty (TKA) with cementless metaphyseal sleeves without stems either in the femoral or tibial side or in both.

Methods In this retrospective study, 51 patients (51 knees) operated in the period 2010 to 2015 met the above-mentioned criteria and were invited to a medical examination including X-rays. Forty-six were available for the study. Mean follow-up was 37 months. Knee Society score (KSS) (objective knee score), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score, and range of motion (ROM) were used as outcome scores and compared with baseline values. X-rays were also examined and compared with postoperative exams to evaluate the presence of loosening, radiolucent lines, and bone ingrowth. Satisfaction of the patients was also investigated using a linear scale from 1 to 10.

Results KSS improved from 39 to 77 (p < 0.01); WOMAC score improved from 76 to 41 (p < 0.01). Twenty-four (52%) patients were satisfied, 15 (32%) were partially satisfied, and 7 (16%) were unsatisfied. ROM improved from 93 to 96 degrees (nonsignificant difference). X-rays showed no loosening of the implants, radiolucent lines in 4 patients (3 of them were asymptomatic) and bone ingrowth in 43 out of 46 patients.

Conclusion In this short-term retrospective study, the use of sleeves without stem was a safe and effective procedure in revision TKA. We found a significant improvement in clinical results compared with baseline values and no signs of implant loosening.

Level of Evidence Level IV, therapeutic case series.